Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer)

被引:3
|
作者
Zengarini, C. [1 ,2 ]
Misciali, C. [1 ,2 ]
Ferrari, T. [1 ,2 ]
Dika, E. [1 ,2 ]
La Placa, M. [1 ,2 ]
Piraccini, B. M. [1 ,2 ]
Baraldi, C. [1 ,2 ]
机构
[1] IRCCS Azienda Osped Univ Bologna, Dermatol Unit, Bologna, Italy
[2] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy
关键词
D O I
10.1111/jdv.18154
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E622 / E623
页数:2
相关论文
共 50 条
  • [21] Eruptive angiomatosis after SARS-CoV-2 vaccine (Comirnaty, Pfizer)
    Zengarini, C.
    Misciali, C.
    Lazzarotto, T.
    Dika, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) : E90 - E91
  • [22] Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
    Yanay, Noa Berar
    Freiman, Sarit
    Shapira, Ma'anit
    Wishahi, Samar
    Hamze, Munir
    Elhaj, Mohamad
    Zaher, Maha
    Armaly, Zaher
    KIDNEY INTERNATIONAL, 2021, 99 (06) : 1496 - 1498
  • [23] Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
    Vietri, Maria Teresa
    D'Elia, Giovanna
    Caliendo, Gemma
    Passariello, Luana
    Albanese, Luisa
    Molinari, Anna Maria
    Angelillo, Italo Francesco
    VACCINE, 2022, 40 (39) : 5726 - 5731
  • [24] Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
    Tomer Hertz
    Shlomia Levy
    Daniel Ostrovsky
    Hanna Oppenheimer
    Shosh Zismanov
    Alona Kuzmina
    Lilach M. Friedman
    Sanja Trifkovic
    David Brice
    Lin Chun-Yang
    Liel Cohen-Lavi
    Yonat Shemer-Avni
    Merav Cohen-Lahav
    Doron Amichay
    Ayelet Keren-Naus
    Olga Voloshin
    Gabriel Weber
    Ronza Najjar-Debbiny
    Bibiana Chazan
    Maureen A. McGargill
    Richard Webby
    Michal Chowers
    Lena Novack
    Victor Novack
    Ran Taube
    Lior Nesher
    Orly Weinstein
    Nature Communications, 14
  • [25] Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
    Hertz, Tomer
    Levy, Shlomia
    Ostrovsky, Daniel
    Oppenheimer, Hanna
    Zismanov, Shosh
    Kuzmina, Alona
    Friedman, Lilach M.
    Trifkovic, Sanja
    Brice, David
    Chun-Yang, Lin
    Cohen-Lavi, Liel
    Shemer-Avni, Yonat
    Cohen-Lahav, Merav
    Amichay, Doron
    Keren-Naus, Ayelet
    Voloshin, Olga
    Weber, Gabriel
    Najjar-Debbiny, Ronza
    Chazan, Bibiana
    McGargill, Maureen A.
    Webby, Richard
    Chowers, Michal
    Novack, Lena
    Novack, Victor
    Taube, Ran
    Nesher, Lior
    Weinstein, Orly
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [26] The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis
    Gilan, Adi
    Laster-Haim, Sarit
    Rottenstreich, Amihai
    Porat, Shay
    Lessans, Naama
    Saar, Tal D.
    Dior, Uri P.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2023, 307 (01) : 121 - 127
  • [27] The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis
    Adi Gilan
    Sarit Laster-Haim
    Amihai Rottenstreich
    Shay Porat
    Naama Lessans
    Tal D. Saar
    Uri P. Dior
    Archives of Gynecology and Obstetrics, 2023, 307 : 121 - 127
  • [28] Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine
    Carneiro, Reis D.
    Matos, A.
    Morgadinho, A.
    REVUE NEUROLOGIQUE, 2022, 178 (1-2) : 160 - 161
  • [29] Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study
    Shasha, David
    Bareket, Ronen
    Sikron, Fabienne Hershkowitz
    Gertel, Omer
    Tsamir, Judith
    Dvir, David
    Mossinson, David
    Heymann, Anthony D.
    Zacay, Galia
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (01) : 130 - 134
  • [30] Longitudinal study of the antibody response after vaccination against SARS-CoV-2 with the BNT162b2 vaccine from Pfizer-BioNtech
    Navas, Leandra J. Robles
    Huete, Juan J. Ortega
    Sanchis, Maria L. Julia
    Miro, Jorge S. Bravo
    Sanchez, Serezade Cervera
    Gasset, Ricardo Molina
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 303 - 307